Universe · entity
Soleus Capital Management, L.P.
Institutional manager (13F) · CIK 1802630
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $2.3B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | KRYSTAL BIOTECH INC | $298M | 1,153,087 |
| 2 | CELCUITY INC | $147M | 1,284,378 |
| 3 | TG THERAPEUTICS INC | $134M | 4,029,319 |
| 4 | INSULET CORP | $118M | 562,500 |
| 5 | NOVOCURE LTD | $114M | 10,492,391 |
| 6 | UNITED THERAPEUTICS CORP DEL | $111M | 187,187 |
| 7 | PRAXIS PRECISION MEDICINES I | $106M | 330,517 |
| 8 | VERICEL CORP | $82M | 2,549,079 |
| 9 | ALKERMES PLC | $70M | 1,970,864 |
| 10 | ANI PHARMACEUTICALS INC | $63M | 820,243 |
| 11 | GLOBUS MED INC | $63M | 729,467 |
| 12 | GERON CORP | $62M | 41,508,659 |
| 13 | TWIST BIOSCIENCE CORP | $58M | 1,226,629 |
| 14 | EDGEWISE THERAPEUTICS INC | $46M | 1,449,915 |
| 15 | BETA BIONICS INC | $44M | 4,354,501 |
| 16 | ALNYLAM PHARMACEUTICALS INC | $44M | 131,650 |
| 17 | SYNDAX PHARMACEUTICALS INC | $40M | 1,726,908 |
| 18 | INDIVIOR PHARMACEUTICALS INC | $39M | 1,274,000 |
| 19 | NEUROPACE INC | $39M | 2,932,207 |
| 20 | LIVANOVA PLC | $37M | 582,500 |
| 21 | MIRUM PHARMACEUTICALS INC | $37M | 400,306 |
| 22 | BIOMARIN PHARMACEUTICAL INC | $37M | 650,572 |
| 23 | PROGYNY INC | $35M | 2,067,000 |
| 24 | INSPIRE MED SYS INC | $30M | 576,299 |
| 25 | EDAP TMS S A | $27M | 7,309,254 |
| 26 | KINIKSA PHARMACEUTICALS INTL | $25M | 521,353 |
| 27 | MERCK & CO INC | $24M | 203,000 |
| 28 | ORGANOGENESIS HLDGS INC | $24M | 10,085,951 |
| 29 | NATERA INC | $24M | 119,000 |
| 30 | AXOGEN INC | $23M | 679,170 |
| 31 | VAXCYTE INC | $22M | 385,472 |
| 32 | ICON PLC | $21M | 192,000 |
| 33 | PHARVARIS N V | $20M | 702,052 |
| 34 | CERUS CORP | $20M | 10,753,700 |
| 35 | TREVI THERAPEUTICS INC | $19M | 1,620,000 |
| 36 | INHIBIKASE THERAPEUTICS INC | $18M | 10,875,000 |
| 37 | CONTEXT THERAPEUTICS INC | $18M | 6,963,141 |
| 38 | VIR BIOTECHNOLOGY INC | $18M | 2,002,000 |
| 39 | XENON PHARMACEUTICALS INC | $17M | 292,000 |
| 40 | TRAVERE THERAPEUTICS INC | $16M | 546,000 |
| 41 | TANDEM DIABETES CARE INC | $15M | 783,000 |
| 42 | NURIX THERAPEUTICS INC | $15M | 938,163 |
| 43 | UROGEN PHARMA LTD | $13M | 727,000 |
| 44 | SIONNA THERAPEUTICS INC | $12M | 293,500 |
| 45 | CORCEPT THERAPEUTICS INC | $12M | 285,531 |
| 46 | JADE BIOSCIENCES INC | $11M | 796,744 |
| 47 | VERACYTE INC | $10M | 319,912 |
| 48 | INVIVYD INC | $10M | 7,708,727 |
| 49 | C4 THERAPEUTICS INC | $10M | 3,803,942 |
| 50 | ORTHOPEDIATRICS CORP | $10M | 615,447 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.